+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07259317

Phase 2 Study of Relacorilant with Nab-Paclitaxel and Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Led by Corcept Therapeutics · Updated on 2026-09-25

80

Participants Needed

20

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, dosing, pharmacokinetics, and effectiveness of relacorilant combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic adenocarcinoma who have not received chemotherapy before. This Phase 2 study aims to find the best dose and schedule of these drugs to help treat this aggressive cancer. The study has two parts. In Part 1, small groups of patients receive different doses and schedules of relacorilant taken orally and nab-paclitaxel and gemcitabine given by intravenous infusion to find the maximum tolerated dose. Relacorilant is taken daily for three days around the chemotherapy treatment days. If a suitable dose is found, Part 2 will enroll more patients to receive this optimal dose combination. The study may adjust or pause enrollment based on safety reviews. Participants will be closely monitored throughout the study. Safety assessments include tracking dose-limiting toxicities and adverse events leading to dose changes or stopping treatment. Effectiveness will be measured by progression-free survival and overall survival over several months. Blood samples will be collected to study drug levels and tumor markers. Participants will have regular visits for treatment, scans, and lab tests. The total study duration may extend up to 19 months for some outcomes.

CONDITIONS

Brief Title

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Research Team

C

Corcept Therapeutics

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here